← ANALYST RATINGS · TIPRANKS
Merit Medical Systems (MMSI): analyst forecast and price target
Analyst consensus
Moderate Buy5 Buy2 Hold0 Sell
Ratings of 7 analysts in the last 3 months · top analysts only12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $98.50, the highest $114, the lowest $83.00. The average is +10.4% from the last price of $89.20.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | $114 | Buy | +27.8% | Reiterated | 12.10.26on TipRanks 07:50 | +3.0%next day −1.8% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $101 | Buy | +13.2% | Reiterated | 29.09.26on TipRanks 05:35 | +1.2%next day −1.7% · 5 days −5.3% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $106 | Buy | +18.8% | Reiterated | 18.09.26on TipRanks 07:45 | −0.4%next day −1.4% · 5 days +1.2% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $95.00 → $105+10.5% | Buy | +17.7% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $91.00 → $105+15.4% | Buy | +17.7% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $91.00 → $102+12.1% | Buy | +14.3% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $88.00 → $101+14.8% | Hold | +13.2% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $93.00 → $104+11.8% | Buy | +16.6% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $102 → $106+3.9% | Buy | +18.8% | Reiterated | 21.08.26on TipRanks Aug 20 22:05 | — | |
| John Young CFA★★★★★★★★★★#10305 · hits 40% · avg −2.8% | Canaccord Genuity | $94.00 | Buy | +5.4% | Reiterated | 11.08.26on TipRanks Aug 12 07:20 | +1.8%next day −0.2% · 5 days −1.6% | ↗ |
| Sam Eiber★★★★★★★★★★#4161 · hits 53% · avg +8.6% | BTIG | $105 | Buy | +17.7% | Reiterated | 11.08.26on TipRanks 06:55 | +1.8%next day −0.2% · 5 days −1.6% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $95.00 | Buy | +6.5% | Reiterated | 04.08.26on TipRanks Aug 5 08:08 | −1.5%next day +1.8% · 5 days +6.3% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | — | Hold | — | Reiterated | 31.07.26on TipRanks 12:22 | +1.3%next day −0.8% · 5 days +1.2% | ↗ |
| Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% | Raymond James | $83.00 → $100+20.5% | Buy | +12.1% | Reiterated | 31.07.26on TipRanks 08:55 | +1.3%next day −0.8% · 5 days +1.2% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $89.00 → $98.00+10.1% | Buy | +9.9% | Reiterated | 31.07.26on TipRanks 07:26 | +1.3%next day −0.8% · 5 days +1.2% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $74.00 → $83.00+12.2% | Hold | −7.0% | Assigned | 31.07.26on TipRanks 07:18 | +1.3%next day −0.8% · 5 days +1.2% | ↗ |
| James Sidoti★★★★★★★★★★#5400 · hits 42% · avg +4.7% | Sidoti | $122 | Buy | +36.8% | Reiterated | 09.01.26on TipRanks 09:10 | −8.0%next day −3.8% · 5 days −4.4% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Merit Medical Systems
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $99.56 at a price of $86.23 (+15.5%); now: $99.56 at $89.20 (+11.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 6 | 6 | 9 | 6 | 7 | 4 |
| Hold | 1 | 1 | 2 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.03 (from $1.01 to $1.05). Last quarter: $1.19.
Sales
Next quarter’s sales estimate — $410M (from $409M to $412M). Last quarter: $419M.
Best top-analyst consensus in the sector · Healthcare
About Merit Medical Systems
- CEO: Martha Goldberg Aronson
- Employees: 7,500
- 1600 West Merit Parkway, South Jordan, UT, 84095, US
- www.merit.com
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in
Data from the stock’s TipRanks forecast page, read 33 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗